VC  Third Rock Ventures

https://www.thirdrockventures.com/





     Office Locations:

29 Newbury Street, 301
Boston, MA 02116
Phone: 617-585-2000
Fax: 617-859-2891

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2007, Third Rock Ventures has over $1.3 billion under management for exclusive investment in life-sciences, primarily in biotechnology, biopharmaceutical, and medical device companies. The firm's strategy is to lead investing rounds and continue with a significant stake in uniquely innovative life sciences businesses, making an initial investment of up to $35 million. Third Rock was founded by four ex-Millennium Pharma executives, including former Millennium CEO, Mark Levin. The firm announced the final closing of Fund III (March 2013), raising $516 million in an oversubscribed fund. Third Rock announced the closing of Third Rock Ventures IV, LP October of 2016, raising $616 million in an oversubscribed fund. The firm has 58 portfolio companies. Third Rock Ventures announced (June 2022) the closing of Third Rock Ventures Fund VI, raising $1.1 billion


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Abbie Celniker PhD Partner
    Carol Speredelozzi Director of Operations and Administration
    Cary Pfeffer MD Partner
    Charles Homcy MD Partner
    Kevin Gillis Partner & Chief Operating Officer

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/15/2022


      Casma Therapeutics


      MA


      $46,000,000


      Series C


      05/26/2022


      Terremoto Biosciences


      CA


      $75,000,000


      Series A


     

    Portfolio companies include:

     

    Recent News: